Home
Conditions
HIV I Infection

Clinical trial condition

HIV I Infection

Explore clinical trials studying HIV I Infection. Study availability and eligibility vary by location and protocol.

26 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

HIV I Infection trial results

Completed

Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

NCT04618198

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations: Kibong'oto Infectious Diseases Hospital Sanya Juu, Tanzania

Mbarara University Science Technology Mbarara, Uganda

View Trial Details

Completed

ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa

NCT06214910

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations: Human Sciences Research Council Sweetwaters, KwaZulu-Natal, South Africa

View Trial Details

Completed

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

NCT05601128

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: Allegheny Health Network Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV

NCT05854381

Conditions: HIV I Infection
Locations: Alabama CRS Birmingham, Alabama, United States

The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States

Beth Israel Deconess Medical Center VCRS Boston, Massachusetts, United States

Penn Prevention CRS Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV

NCT04820933

Conditions: Cardiovascular Diseases, Cardiovascular Risk Factor, HIV I Infection, +3 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

University of Texas Southwestern Dallas, Texas, United States

View Trial Details

Completed

Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol

NCT04971343

Conditions: HIV I Infection, HIV-2 Infection
Locations: Etablissement Français du Sang (EFS) Hauts-de-France - Normandie Bois-Guillaume, France

Eurofins Biomnis Ivry-sur-Seine, France

Qbd, Efs Hfno Loos, France

UPR Lille, Établissement français du sang Hauts-de-France - Normandie Loos, France

View Trial Details

Completed

Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF

NCT04585737

Conditions: HIV I Infection
Locations: Orlando Immunology Center Orlando, Florida, United States

View Trial Details

Completed

The Visceral Adiposity Measurement and Observation Study

NCT05383456

Conditions: Acquired Immunodeficiency Syndrome, BMI, Blood-Borne Infections, +47 more
Locations: Ruane Clinical Research Los Angeles, California, United States

AIDS Healthcare Foundation Fort Lauderdale, Florida, United States

AIDS Healthcare Foundation Miami Beach, Florida, United States

AIDS Healthcare Foundation Miami Beach, Florida, United States

View Trial Details

Completed

Acute Effects of TCIG vs ECIG in PLWH

NCT04568395

Conditions: Behavior, Chemically-Induced Disorders, E Cigarette Use, +14 more
Locations: UCLA Los Angeles, California, United States

UCaliforniaLA Los Angeles, California, United States

View Trial Details

Completed

Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism

NCT04675255

Conditions: Adiposity, Body Weight, HIV I Infection, +7 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

HIV I Infection

HIV I Infection trial results

Related conditions